US Drug Shortages Aid Aurobindo’s Q4 Growth, Decentralized Trials On For Xolair Biosimilar

Generic Revlimid Launch In October

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.